Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) EPS (Basic) (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed EPS (Basic) for 3 consecutive years, with -$0.84 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) fell 162.22% to -$0.84 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.42 through Dec 2025, up 91.19% year-over-year, with the annual reading at -$3.43 for FY2025, 40.96% up from the prior year.
  • EPS (Basic) for Q4 2025 was -$0.84 at Artiva Biotherapeutics, up from -$0.88 in the prior quarter.
  • The five-year high for EPS (Basic) was $13.98 in Q3 2023, with the low at -$22.0 in Q2 2024.
  • Average EPS (Basic) over 3 years is -$5.2, with a median of -$0.88 recorded in 2025.
  • The sharpest move saw EPS (Basic) soared 109.07% in 2024, then plummeted 162.22% in 2025.
  • Over 3 years, EPS (Basic) stood at -$14.89 in 2023, then skyrocketed by 109.07% to $1.35 in 2024, then tumbled by 162.22% to -$0.84 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at -$0.84, -$0.88, and -$0.87 for Q4 2025, Q3 2025, and Q2 2025 respectively.